Smart Drops, ‘Nature’s Liquid Adderall’
Bogus report leads to unapproved health claims.
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)
Bogus report leads to unapproved health claims.
Lawsuits take aim at so-called non-disparagement clauses.
The consumer advocacy organization truthinadvertising.org (TINA.org) has published the results of a yearslong investigation into the multilevel marketing (MLM) industry that found widespread use of deceptive income claims to promote…
Why you may find it hard to “do your slice.”
TINA.org investigation finds 98% of MLMs using misleading income claims.